Maria Patrizia Caldirola
Amministratore Delegato presso ClanoTech AB
Provenienza dei contatti di primo grado di Maria Patrizia Caldirola
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
ClanoTech AB
ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Statistiche
Distribuzione geografica
Svezia | 2 |
Danimarca | 2 |
Settori
Consumer Services | 3 |
Posizioni
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Director/Board Member | 1 |
Founder | 1 |
Contatti più connessi
Insiders | |
---|---|
Yihai Cao | 3 |
- Borsa valori
- Insiders
- Maria Patrizia Caldirola
- Connessioni Società